skinny.

Latest / The Podcast by KevinMD

How in silico drug development can improve patient outcomes

"In silico technologies also enable drug developers to perform, in theory, an unlimited number of tests using a wide range of variables that include age, sex, and the health status of each member of the virtual patient pool, compared to the more restrictive parameters of a traditional trial. By reducing the amount of trial and error involved in collecting data, drug developers can focus on therapies that prove to be more effective in treating a specific group of patients."

Tanja Dowe is a health care executive.

She shares her story and discusses her KevinMD article, "The promise of in silico…

Log in to save or queue this episode.

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.